| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bae8261aa0146620917d76a004c2cabd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate |
2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d149fcf0c9ef07a1dd4c23fb3c70b7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69a4b21ed3d81e6d84103a935940055c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09285807ad3b8b51e735020a2c578fea |
| publicationDate |
2015-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150130319-A |
| titleOfInvention |
Concentrated aqueous azalide formulations |
| abstract |
The present invention relates to a method for preparing azithromycin, comprising the steps of: preparing a concentrated aqueous formulation of azithromycin at about 2% -20%; preparing and sterilizing a first solution comprising a strong base to produce a sterilized solution; In an aqueous solution comprising the acid and a step of adding an aqueous solution comprising the strong acid to a sterile solution comprising a strong base to provide a concentrated aqueous formulation of azithromycin do. The strong acid has a pKa of less than about -1.74 and the process is carried out without the addition of weak acids or without the use of weak acids. |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |